Replies to post #254867 on Biotech Values

[Whalatane]

RGLS. thx

Cash, Cash Equivalents and Short-term Investments: As of December 31, 2024, Regulus had $75.8 million in cash, cash equivalents and short-term investments. The Company expects its cash runway to extend into early 2026.

So count down to a cash raise ...based in San Diego so please excuse my SF / Bay Area biotech snobbery :---)
Kiwi